59 related articles for article (PubMed ID: 10951520)
1. Stability and haplotype analysis of the FRAXE region.
Murray A; Ennis S; Youings SA; Sharrock AJ; Lewis C; Pound MC; Macpherson JN; Dennis NR; Morton NE; Jacobs PA
Eur J Hum Genet; 2000 Aug; 8(8):583-9. PubMed ID: 10951520
[TBL] [Abstract][Full Text] [Related]
2. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males.
Barros Santos C; Gonçalves Pimentel MM
Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656
[TBL] [Abstract][Full Text] [Related]
3. A survey of FRAXE allele sizes in three populations.
Zhong N; Ju W; Curley D; Wang D; Pietrofesa J; Wu G; Shen Y; Pang C; Poon P; Liu X; Gou S; Kajanoja E; Ryynänen M; Dobkin C; Brown WT
Am J Med Genet; 1996 Aug; 64(2):415-9. PubMed ID: 8844095
[TBL] [Abstract][Full Text] [Related]
4. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males.
Santos CB; Costa Lima MA; Pimentel MM
Hum Mutat; 2001 Aug; 18(2):157-62. PubMed ID: 11462240
[TBL] [Abstract][Full Text] [Related]
5. The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission.
Murray A; Macpherson JN; Pound MC; Sharrock A; Youings SA; Dennis NR; McKechnie N; Linehan P; Morton NE; Jacobs PA
Hum Mol Genet; 1997 Feb; 6(2):173-84. PubMed ID: 9063737
[TBL] [Abstract][Full Text] [Related]
6. Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities.
Holden JJ; Julien-Inalsingh C; Chalifoux M; Wing M; Scott E; Fidler K; Swift I; Maidment B; Knight SJ; Davies KE; White BN
Am J Med Genet; 1996 Aug; 64(2):420-3. PubMed ID: 8844096
[TBL] [Abstract][Full Text] [Related]
7. Founder haplotype for Machado-Joseph disease in the Indian population: novel insights from history and polymorphism studies.
Mittal U; Srivastava AK; Jain S; Jain S; Mukerji M
Arch Neurol; 2005 Apr; 62(4):637-40. PubMed ID: 15824265
[TBL] [Abstract][Full Text] [Related]
8. Haplotypic determinants of instability in the FRAX region: Concatenated mutation or founder effect?
Ennis S; Murray A; Morton NE
Hum Mutat; 2001; 18(1):61-9. PubMed ID: 11438994
[TBL] [Abstract][Full Text] [Related]
9. Haplotype analysis at the FRAXA locus in Thai subjects.
Limprasert P; Saechan V; Ruangdaraganon N; Sura T; Vasiknanote P; Jaruratanasirikul S; Brown WT
Am J Med Genet; 2001 Jan; 98(3):224-9. PubMed ID: 11169559
[TBL] [Abstract][Full Text] [Related]
10. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers.
Murray A; Youings S; Dennis N; Latsky L; Linehan P; McKechnie N; Macpherson J; Pound M; Jacobs P
Hum Mol Genet; 1996 Jun; 5(6):727-35. PubMed ID: 8776586
[TBL] [Abstract][Full Text] [Related]
11. Haplotype analysis of the myotonic dystrophy type 1 (DM1) locus in Taiwan: implications for low prevalence and founder mutations of Taiwanese myotonic dystrophy type 1.
Pan H; Lin HM; Ku WY; Li TC; Li SY; Lin CC; Hsiao KM
Eur J Hum Genet; 2001 Aug; 9(8):638-41. PubMed ID: 11528511
[TBL] [Abstract][Full Text] [Related]
12. FRAXE intermediate alleles are associated with Parkinson's disease.
Annesi G; Nicoletti G; Tarantino P; Cutuli N; Annesi F; Marco EV; Zappia M; Morgante L; Arabia G; Pugliese P; Condino F; Carrideo S; Civitelli D; Caracciolo M; Romeo N; Spadafora P; Candiano IC; Quattrone A
Neurosci Lett; 2004 Sep; 368(1):21-4. PubMed ID: 15342126
[TBL] [Abstract][Full Text] [Related]
13. FRAXA and FRAXE: the results of a five year survey.
Youings SA; Murray A; Dennis N; Ennis S; Lewis C; McKechnie N; Pound M; Sharrock A; Jacobs P
J Med Genet; 2000 Jun; 37(6):415-21. PubMed ID: 10851251
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of GAA repeats and four linked bi-allelic markers in and around the frataxin gene in patients and normal populations from India.
Chattopadhyay B; Gupta S; Gangopadhyay PK; Das SK; Roy T; Mukherjee SC; Sinha KK; Singhal BS; Bhattacharyya NP
Ann Hum Genet; 2004 May; 68(Pt 3):189-95. PubMed ID: 15180699
[TBL] [Abstract][Full Text] [Related]
16. FRAXE mutation analysis in three Spanish families.
Carbonell P; López I; Gabarrón J; Bernabé MJ; Lucas JM; Guitart M; Gabau E; Glover G
Am J Med Genet; 1996 Aug; 64(2):434-40. PubMed ID: 8844099
[TBL] [Abstract][Full Text] [Related]
17. Lack of FMR3 expression in a male with non-syndromic mental retardation and a microdeletion immediately distal to FRAXE CCG repeat.
Santos-Rebouças CB; Abdalla CB; Fullston T; Campos M; Pimentel MM; Gécz J
Neurosci Lett; 2006 Apr; 397(3):245-8. PubMed ID: 16469443
[TBL] [Abstract][Full Text] [Related]
18. Trinucleotide repeats at the FRAXF locus: frequency and distribution in the general population.
Holden JJ; Walker M; Chalifoux M; White BN
Am J Med Genet; 1996 Aug; 64(2):424-7. PubMed ID: 8844097
[TBL] [Abstract][Full Text] [Related]
19. Analysis of FMR1 (CGG)(n) alleles and DXS548-FRAXAC1 haplotypes in three European circumpolar populations: traces of genetic relationship with Asia.
Larsen LA; Vuust J; Nystad M; Evseeva I; Van Ghelue M; Tranebjaerg L
Eur J Hum Genet; 2001 Sep; 9(9):724-7. PubMed ID: 11571563
[TBL] [Abstract][Full Text] [Related]
20. Possible founder effects for FRAXE alleles.
Limprasert P; Zhong N; Currie JR; Brown WT
Am J Med Genet; 1999 May; 84(3):286-90. PubMed ID: 10331609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
